Table of contents:
Latest news & events
Featured presentation
In our own words
IR HOME
News & Events
Press releases
Events
Presentations
Financials
SEC filings
Longitudinal Reporting
Leadership
Executive leadership
Board of directors
Governance documents
Committee composition
Resources
Investor contact
RSS feeds
MENU
Investor Relations
Latest
March 12, 2024
Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification
READ MORE
OTC: NVTA
0.02
+
0.00
+
0%
Volume:
1,192,449
20 minute delay
March 18, 2024
IR HOME
News & Events
Press releases
Events
Presentations
Financials
SEC filings
Longitudinal Reporting
Leadership
Executive leadership
Board of directors
Governance documents
Committee composition
Resources
Investor contact
RSS feeds
INVITAE HOME
Latest
March 12, 2024
Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification
READ MORE
OTC: NVTA
0.02
+
0.00
+
0%
Volume:
1,192,449
20m delay
March 18, 2024
Latest news & events
Feature presentation
Events
Investor Toolkit
Email Alerts
Sign up to receive Invitae financial information by email.
Email Address:
*
I'D LIKE TO RECEIVE EMAILS ABOUT:
*
Press Release
SEC Filing
Presentation
Event
End of Day Stock Quote
Enter the code shown above.
Investor Contact
1400 16th St.
San Francisco, CA, 94103
Email:
[email protected]
Privacy
|
Terms
|
Licensing
|
Contact
© Invitae Corporation. All rights reserved.
Powered By Q4 Inc.
5.117.1.12